Huo L - Search Results

1

A phase II study of Mirvetuximab Soravtansine in triple-negative breast cancer.

Yam C, Rauch GM, Rahman T, Karuturi M, Ravenberg E, White J, Clayborn A, McCarthy P, Abouharb S, Lim B, Litton JK, Ramirez DL, Saleem S, Stec J, Symmans WF, Huo L, Damodaran S, Sun R, Moulder SL. Yam C, et al. Among authors: huo l. Invest New Drugs. 2021 Apr;39(2):509-515. doi: 10.1007/s10637-020-00995-2. Epub 2020 Sep 28. Invest New Drugs. 2021. PMID: 32984932 Clinical Trial.

2

Metaplastic sarcomatoid carcinoma of the breast appears more aggressive than other triple receptor-negative breast cancers.

Lester TR, Hunt KK, Nayeemuddin KM, Bassett RL Jr, Gonzalez-Angulo AM, Feig BW, Huo L, Rourke LL, Davis WG, Valero V, Gilcrease MZ. Lester TR, et al. Among authors: huo l. Breast Cancer Res Treat. 2012 Jan;131(1):41-8. doi: 10.1007/s10549-011-1393-6. Epub 2011 Feb 18. Breast Cancer Res Treat. 2012. PMID: 21331622 Free PMC article.

3

Which threshold for ER positivity? a retrospective study based on 9639 patients.

Yi M, Huo L, Koenig KB, Mittendorf EA, Meric-Bernstam F, Kuerer HM, Bedrosian I, Buzdar AU, Symmans WF, Crow JR, Bender M, Shah RR, Hortobagyi GN, Hunt KK. Yi M, et al. Among authors: huo l. Ann Oncol. 2014 May;25(5):1004-11. doi: 10.1093/annonc/mdu053. Epub 2014 Feb 20. Ann Oncol. 2014. PMID: 24562447 Free PMC article.

4

Expression of androgen receptor in inflammatory breast cancer and its clinical relevance.

Gong Y, Wei W, Wu Y, Ueno NT, Huo L. Gong Y, et al. Among authors: huo l. Cancer. 2014 Jun 15;120(12):1775-9. doi: 10.1002/cncr.28667. Epub 2014 Mar 13. Cancer. 2014. PMID: 24634055 Free article.

5

Breast conservation in the setting of contemporary multimodality treatment provides excellent outcomes for patients with occult primary breast cancer.

Rueth NM, Black DM, Limmer AR, Gabriel E, Huo L, Fornage BD, Dogan BE, Chavez-MacGregor M, Yi M, Hunt KK, Strom EA. Rueth NM, et al. Among authors: huo l. Ann Surg Oncol. 2015 Jan;22(1):90-5. doi: 10.1245/s10434-014-3991-0. Epub 2014 Sep 24. Ann Surg Oncol. 2015. PMID: 25249256 Clinical Trial.

6

GATA-binding protein 3 enhances the utility of gross cystic disease fluid protein-15 and mammaglobin A in triple-negative breast cancer by immunohistochemistry.

Huo L, Gong Y, Guo M, Gilcrease MZ, Wu Y, Zhang H, Zhang J, Resetkova E, Hunt KK, Deavers MT. Huo L, et al. Histopathology. 2015 Aug;67(2):245-54. doi: 10.1111/his.12645. Epub 2015 Feb 23. Histopathology. 2015. PMID: 25564996

7

MicroRNA expression profiling identifies decreased expression of miR-205 in inflammatory breast cancer.

Huo L, Wang Y, Gong Y, Krishnamurthy S, Wang J, Diao L, Liu CG, Liu X, Lin F, Symmans WF, Wei W, Zhang X, Sun L, Alvarez RH, Ueno NT, Fouad TM, Harano K, Debeb BG, Wu Y, Reuben J, Cristofanilli M, Zuo Z. Huo L, et al. Mod Pathol. 2016 Apr;29(4):330-46. doi: 10.1038/modpathol.2016.38. Epub 2016 Feb 26. Mod Pathol. 2016. PMID: 26916073 Free article.

8

Impact of androgen receptor expression in fluoxymesterone-treated estrogen receptor-positive metastatic breast cancer refractory to contemporary hormonal therapy.

Kono M, Fujii T, Lyons GR, Huo L, Bassett R, Gong Y, Karuturi MS, Tripathy D, Ueno NT. Kono M, et al. Among authors: huo l. Breast Cancer Res Treat. 2016 Nov;160(1):101-109. doi: 10.1007/s10549-016-3986-6. Epub 2016 Sep 23. Breast Cancer Res Treat. 2016. PMID: 27663436

9

Triple-negative breast cancer has worse overall survival and cause-specific survival than non-triple-negative breast cancer.

Li X, Yang J, Peng L, Sahin AA, Huo L, Ward KC, O'Regan R, Torres MA, Meisel JL. Li X, et al. Among authors: huo l. Breast Cancer Res Treat. 2017 Jan;161(2):279-287. doi: 10.1007/s10549-016-4059-6. Epub 2016 Nov 25. Breast Cancer Res Treat. 2017. PMID: 27888421

10

Androgen receptor expression on circulating tumor cells in metastatic breast cancer.

Fujii T, Reuben JM, Huo L, Espinosa Fernandez JR, Gong Y, Krupa R, Suraneni MV, Graf RP, Lee J, Greene S, Rodriguez A, Dugan L, Louw J, Lim B, Barcenas CH, Marx AN, Tripathy D, Wang Y, Landers M, Dittamore R, Ueno NT. Fujii T, et al. Among authors: huo l. PLoS One. 2017 Sep 28;12(9):e0185231. doi: 10.1371/journal.pone.0185231. eCollection 2017. PLoS One. 2017. PMID: 28957377 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,441 results

Search Page